Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 4/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21075897 | 0.91 | CA2 (0.40) | CA2LMNATP53CES1FAAH | |
| SCHEMBL17369606 | 0.90 | LMNA (0.41) | CA2LMNATP53BLM | |
| SCHEMBL1704445 | 0.85 | TP53 (0.32) | CA2TP53 | |
| SCHEMBL13784413 | 0.85 | LMNA (0.38) | CA2LMNATP53CES1BLM | |
| SCHEMBL28939095 | 0.82 | LMNA (0.46) | CA2LMNATP53CES1BLM | |
| SCHEMBL27741673 | 0.82 | CA2 (0.47) | CA2LMNATP53CES1FAAH | |
| SCHEMBL6890549 | 0.81 | CA2 (0.40) | CA2LMNATP53CES1FAAH | |
| SCHEMBL28470985 | 0.80 | LMNA (0.43) | CA2LMNATP53CES1BLM | |
| SCHEMBL28302019 | 0.80 | LMNA (0.43) | CA2LMNATP53CES1BLM | |
| SCHEMBL19002208 | 0.78 | LMNA (0.42) | CA2LMNATP53CES1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9583272-B2 | Electrolyte solution for electrochemical devices, aluminum electrolytic capacitor, and electric double layer capacitor | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2017-02-28 | — | — | US | disclosed |
| US-20150076389-A1 | ELECTROLYTE SOLUTION FOR ELECTROCHEMICAL DEVICES, ALUMINUM ELECTROLYTIC CAPACITOR, AND ELECTRIC DOUBLE LAYER CAPACITOR | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2015-03-19 | — | — | US | disclosed |
| EP-2833381-A1 | ELECTROLYTE SOLUTION FOR ELECTROCHEMICAL DEVICES, ALUMINUM ELECTROLYTIC CAPACITOR, AND ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Seika Chemicals Co., Ltd. (JP) | 2015-02-04 | — | — | EP | disclosed |
| US-20110306797-A1 | SULFONE COMPOUND | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2011-12-15 | — | — | US | disclosed |
| EP-2351735-A1 | SULFONE COMPOUND | Sumitomo Seika Chemicals CO. LTD. (JP) | 2011-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306797-A1 | SULFONE COMPOUND | SULT1E1, SULT1A1, STS | CA2 208/4885LMNA 4085/4885TP53 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.